BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

824 related articles for article (PubMed ID: 15539428)

  • 1. Glucocorticoid receptor ligand binding domain is sufficient for the modulation of glucocorticoid induction properties by homologous receptors, coactivator transcription intermediary factor 2, and Ubc9.
    Cho S; Kagan BL; Blackford JA; Szapary D; Simons SS
    Mol Endocrinol; 2005 Feb; 19(2):290-311. PubMed ID: 15539428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equilibrium interactions of corepressors and coactivators with agonist and antagonist complexes of glucocorticoid receptors.
    Wang Q; Blackford JA; Song LN; Huang Y; Cho S; Simons SS
    Mol Endocrinol; 2004 Jun; 18(6):1376-95. PubMed ID: 15016838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of activation function domain-1, DNA binding, and coactivator GRIP1 in the expression of partial agonist activity of glucocorticoid receptor-antagonist complexes.
    Cho S; Blackford JA; Simons SS
    Biochemistry; 2005 Mar; 44(9):3547-61. PubMed ID: 15736964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of acetylation, polymerase phosphorylation, and DNA unwinding in glucocorticoid receptor transactivation.
    Kim Y; Sun Y; Chow C; Pommier YG; Simons SS
    J Steroid Biochem Mol Biol; 2006 Jul; 100(1-3):3-17. PubMed ID: 16723222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corepressor binding to progesterone and glucocorticoid receptors involves the activation function-1 domain and is inhibited by molybdate.
    Wang D; Simons SS
    Mol Endocrinol; 2005 Jun; 19(6):1483-500. PubMed ID: 15774497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New antiprogestins with partial agonist activity: potential selective progesterone receptor modulators (SPRMs) and probes for receptor- and coregulator-induced changes in progesterone receptor induction properties.
    Giannoukos G; Szapary D; Smith CL; Meeker JE; Simons SS
    Mol Endocrinol; 2001 Feb; 15(2):255-70. PubMed ID: 11158332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of induction properties of glucocorticoid receptor-agonist and -antagonist complexes by coactivators involves binding to receptors but is independent of ability of coactivators to augment transactivation.
    He Y; Szapary D; Simons SS
    J Biol Chem; 2002 Dec; 277(51):49256-66. PubMed ID: 12376547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct interaction of cortivazol with the ligand binding domain confers glucocorticoid receptor specificity: cortivazol is a specific ligand for the glucocorticoid receptor.
    Yoshikawa N; Makino Y; Okamoto K; Morimoto C; Makino I; Tanaka H
    J Biol Chem; 2002 Feb; 277(7):5529-40. PubMed ID: 11741935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations of glucocorticoid receptor differentially affect AF2 domain activity in a steroid-selective manner to alter the potency and efficacy of gene induction and repression.
    Tao YG; Xu Y; Xu HE; Simons SS
    Biochemistry; 2008 Jul; 47(29):7648-62. PubMed ID: 18578507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of transcription parameters in glucocorticoid receptor-mediated repression.
    Sun Y; Tao YG; Kagan BL; He Y; Simons SS
    Mol Cell Endocrinol; 2008 Nov; 295(1-2):59-69. PubMed ID: 18583028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for a common step in three different processes for modulating the kinetic properties of glucocorticoid receptor-induced gene transcription.
    Chen S; Sarlis NJ; Simons SS
    J Biol Chem; 2000 Sep; 275(39):30106-17. PubMed ID: 10899170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure/activity elements of the multifunctional protein, GMEB-1. Characterization of domains relevant for the modulation of glucocorticoid receptor transactivation properties.
    Chen J; Kaul S; Simons SS
    J Biol Chem; 2002 Jun; 277(24):22053-62. PubMed ID: 11934901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations at positions 547-553 of rat glucocorticoid receptors reveal that hsp90 binding requires the presence, but not defined composition, of a seven-amino acid sequence at the amino terminus of the ligand binding domain.
    Kaul S; Murphy PJ; Chen J; Brown L; Pratt WB; Simons SS
    J Biol Chem; 2002 Sep; 277(39):36223-32. PubMed ID: 12145311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposing effects of corepressor and coactivators in determining the dose-response curve of agonists, and residual agonist activity of antagonists, for glucocorticoid receptor-regulated gene expression.
    Szapary D; Huang Y; Simons SS
    Mol Endocrinol; 1999 Dec; 13(12):2108-21. PubMed ID: 10598585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of the N-terminal region of coactivator TIF2 to the intrinsically disordered AF1 domain of the glucocorticoid receptor is accompanied by conformational reorganizations.
    Khan SH; Awasthi S; Guo C; Goswami D; Ling J; Griffin PR; Simons SS; Kumar R
    J Biol Chem; 2012 Dec; 287(53):44546-60. PubMed ID: 23132854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of steroid receptor coactivators in glucocorticoid and transforming growth factor beta regulation of plasminogen activator inhibitor gene expression.
    Li G; Heaton JH; Gelehrter TD
    Mol Endocrinol; 2006 May; 20(5):1025-34. PubMed ID: 16423881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure/activity relationships for GMEB-2: the second member of the glucocorticoid modulatory element-binding complex.
    Chen J; He Y; Simons SS
    Biochemistry; 2004 Jan; 43(1):245-55. PubMed ID: 14705952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand binding domain mutations of the glucocorticoid receptor selectively modify the effects with, but not binding of, cofactors.
    Lee GS; Simons SS
    Biochemistry; 2011 Jan; 50(3):356-66. PubMed ID: 21142156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantity of partial agonist activity for antiglucocorticoids complexed with mutant glucocorticoid receptors is constant in two different transactivation assays but not predictable from steroid structure.
    Sarlis NJ; Bayly SF; Szapary D; Simons SS
    J Steroid Biochem Mol Biol; 1999 Feb; 68(3-4):89-102. PubMed ID: 10369406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ubc9 is a novel modulator of the induction properties of glucocorticoid receptors.
    Kaul S; Blackford JA; Cho S; Simons SS
    J Biol Chem; 2002 Apr; 277(15):12541-9. PubMed ID: 11812797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.